Peptide Sequencing by Edman Degradation
Peptide sequencing by Edman degradation is a well-established and highly effective method for determining the amino acid sequences of peptides and proteins. First introduced by Pehr Edman in 1950, this technique employs a stepwise chemical process to selectively cleave and identify N-terminal amino acids in a peptide chain. Through repeated cycles of cleavage and detection, Edman degradation enables precise determination of the sequential arrangement of amino acids, making it an invaluable tool in proteomics research.
Compared to modern mass spectrometry, peptide sequencing by Edman degradation demonstrates exceptional specificity and reliability, particularly for short peptides (typically 20–50 amino acids). Its unique stepwise approach allows researchers to analyze peptides in a sequence-dependent manner, uncovering the primary structure of proteins. This method has found extensive applications in fields such as basic biology, drug development, disease research, and biomarker identification.
For instance, in protein identification, peptide sequencing by Edman degradation complements mass spectrometry by validating peptide sequences and confirming results. In protein functional studies, it is instrumental in characterizing bioactive peptides and functional domains, providing insights into their structural underpinnings. Additionally, in biopharmaceutical development, this technique facilitates the assessment of product purity, identification of post-translational modification (PTM) sites, and detection of unknown protein contaminants. Thus, peptide sequencing by Edman degradation continues to serve as a critical method in both research and industrial contexts.
The Edman degradation process begins with selective labeling and cleavage of the N-terminal amino acid. The N-terminal residue reacts with phenyl isothiocyanate (PITC) to form a phenylthiocarbamoyl derivative. Under acidic conditions, this derivative undergoes cyclization, cleaving the labeled amino acid from the peptide chain. The resulting cyclic product is separated and identified using high-performance liquid chromatography (HPLC) or other detection methods, revealing the identity of the amino acid. The remaining peptide chain is then subjected to successive cycles of sequencing until the entire sequence is resolved.
Despite its advantages, peptide sequencing by Edman degradation has limitations. The method’s efficiency decreases for longer peptides or complex proteins due to cumulative reaction losses, restricting its effective sequencing length to approximately 50 amino acids. Furthermore, N-terminal modifications such as acetylation or methylation can obstruct the chemical reactions, hindering sequencing. To address these challenges, researchers often combine Edman degradation with complementary techniques like mass spectrometry and enzymatic digestion, thereby improving sequence coverage and analytical accuracy.
MtoZ Biolabs specializes in peptide sequencing by Edman degradation, offering high-quality N-terminal sequencing services tailored to diverse research needs. With a team of experienced professionals and robust analytical workflows, we ensure reliable and comprehensive results for applications ranging from protein identification to biopharmaceutical quality control. By partnering with MtoZ Biolabs, you gain access to precise sequencing solutions that empower your scientific discoveries and industrial innovations.
MtoZ Biolabs, an integrated chromatography and mass spectrometry (MS) services provider.
Related Services
How to order?
